Molecular and Serologic Investigation of the 2021 COVID-19 Case Surge Among Vaccine Recipients in Mongolia

JAMA Netw Open. 2022 Feb 1;5(2):e2148415. doi: 10.1001/jamanetworkopen.2021.48415.

Authors

Naranjargal J Dashdorj¹, Naranbaatar D Dashdorj¹, Mitali Mishra², Lisa Danzig³, Thomas Briese², W Ian Lipkin², Nischay Mishra²

Affiliations

¹ Onom Foundation, Ulaanbaatar, Mongolia.
² Center for Infection and Immunity, Columbia University, New York, New York.
³ Pandefense Advisory, Mill Valley, California.

Abstract

This cross-sectional study uses molecular and serologic methods to investigate the 2021 surge in COVID-19 cases among vaccine recipients in Mongolia.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 / blood
COVID-19 / epidemiology*
COVID-19 Vaccines / blood
Communicable Disease Control / organization & administration
Cross-Sectional Studies
Female
Humans
Male
Mongolia / epidemiology
Retrospective Studies
SARS-CoV-2
Vaccination Coverage / statistics & numerical data*

Substances

COVID-19 Vaccines

Supplementary concepts

COVID-19 breakthrough infections
SARS-CoV-2 variants